Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (501-510 of 910) with videos related to

Pageof 91
Sort By:
JAMA|January 5, 2012
International variation in and factors associated with hospital readmission after myocardial infarctionRobb D Kociol, Renato D Lopes, Robert Clare, et al.
Circulation. Cardiovascular Genetics|October 20, 2011
Effect of heparin administration on metabolomic profiles in samples obtained during cardiac catheterizationMichael P Brunner, Svati H Shah, Damian M Craig, et al.
Circulation|December 19, 2007
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapyJeffrey S Berger, Amanda Stebbins, Christopher B Granger, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMIJames L Januzzi, C Michael Gibson, Gerald Chi, et al.
American Heart Journal|January 7, 2003
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trialsDavid Hasdai, Eric J Topol, Rakhi Kilaru, et al.
Open Heart|February 17, 2022
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trialRobert C Welsh, Payam Dehghani, Renato Lopes, et al.
Critical Care Medicine|October 21, 2010
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini, Phillip J Schulte, Karen S Pieper, et al.
Journal of the American College of Cardiology|March 25, 2014
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesElaine M Hylek, Claes Held, John H Alexander, et al.
Archives of Internal Medicine|October 29, 2003
Predictors of hospital mortality in the global registry of acute coronary eventsChristopher B Granger, Robert J Goldberg, Omar Dabbous, et al.
The Hastings Center Report|August 21, 2019
Bystander Ethics and Good Samaritanism: A Paradox for Learning Health OrganizationsJames E Sabin, Noelle M Cocoros, Crystal J Garcia, et al.
Pageof 91

Showing results (501-510 of 910) with videos related to

Sort By:
Pageof 91
JAMA|January 5, 2012
International variation in and factors associated with hospital readmission after myocardial infarctionRobb D Kociol, Renato D Lopes, Robert Clare, et al.
Circulation. Cardiovascular Genetics|October 20, 2011
Effect of heparin administration on metabolomic profiles in samples obtained during cardiac catheterizationMichael P Brunner, Svati H Shah, Damian M Craig, et al.
Circulation|December 19, 2007
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapyJeffrey S Berger, Amanda Stebbins, Christopher B Granger, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMIJames L Januzzi, C Michael Gibson, Gerald Chi, et al.
American Heart Journal|January 7, 2003
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trialsDavid Hasdai, Eric J Topol, Rakhi Kilaru, et al.
Open Heart|February 17, 2022
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trialRobert C Welsh, Payam Dehghani, Renato Lopes, et al.
Critical Care Medicine|October 21, 2010
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini, Phillip J Schulte, Karen S Pieper, et al.
Journal of the American College of Cardiology|March 25, 2014
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesElaine M Hylek, Claes Held, John H Alexander, et al.
Archives of Internal Medicine|October 29, 2003
Predictors of hospital mortality in the global registry of acute coronary eventsChristopher B Granger, Robert J Goldberg, Omar Dabbous, et al.
The Hastings Center Report|August 21, 2019
Bystander Ethics and Good Samaritanism: A Paradox for Learning Health OrganizationsJames E Sabin, Noelle M Cocoros, Crystal J Garcia, et al.
Pageof 91